🇺🇸 FDA
Patent

US 10369229

Methods and compositions for liposomal formulation of antigens and uses thereof

granted A61KA61K2039/55555A61K2039/55572

Quick answer

US patent 10369229 (Methods and compositions for liposomal formulation of antigens and uses thereof) held by The Regents of the University of California expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/55555, A61K2039/55572, A61K2039/60, A61K2039/6018